Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

Completed2

Suspended1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed250%

suspended125%

unknown125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_1

Clinical Trials (4)

Showing 4 of 4 trials

NCT05228899Phase 1

Zofin to Treat COVID-19 Long Haulers

Completed

NCT04384445Phase 1

Zofin (Organicell Flow) for Patients With COVID-19

Completed

NCT05643729Phase 1

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

Suspended

NCT04657406

Expanded Access to Zofin for Patients With COVID-19

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4